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Abstract

Measurement of Adherence to Antihypertensive Medications in Older Adults Using Selfreport method compared to Prescription Fill records

By Priyanka Parshuram Kakad, B. Pharm., MS
A Thesis submitted in partial fulfillment of the requirements for the degree of Masters of
Science in Pharmaceutical Sciences at Virginia Commonwealth University
.

Virginia Commonwealth University, 2009

Major Director: Dr. Patricia W. Slattum, PharmD, PhD
Director of Geriatric Pharmacotherapy program, Associate Professor and Geriatric
Specialist, Department of Pharmacy

Objective:
To evaluate the level of agreement between two self-reported medication adherence scales
and prescription refill records in older adults.
Design:
Cross-sectional study
Setting:
Imperial Plaza; a retirement community located in Richmond, Virginia.

vii

Participants:
32 independent-living older adults, taking anti-hypertensive medications and filling their
prescriptions at on-site Plaza Professional Pharmacy were recruited in the study.

Methods:
Participants‟ 6 months refill records were obtained and Medication Possession Ration
(MPR) was calculated. Participants were interviewed using Morisky Medication
Adherence Scale (MMAS) & Brief Medication Questionnaire (BMQ). Kappa (k) statistics
was used to evaluate the level of agreement.
Results:
Poor level of agreement was found between refill records and MMAS (k=-0.004), refill
records and BMQ belief screen (k=-0.09), regimen screen ((k=-0.09), and recall screen (k
=-0.004). Strong agreement was found between MMAS and BMQ regimen screen (k=0.79)
and recall screen (k=0.87 resp.)
Conclusion:
Self-reported measure of adherence exhibited poor agreement with prescription refill
records.
.
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CHAPTER 1 INTRODUCTION

Background
Adherence to medications is defined as “the extent to which a person‟s behavior
in taking medication, following a diet, and/or executing lifestyle changes; corresponds
with agreed recommendations from a health care provider” (World health organization,
2003; Osterberg & Blaschke, 2005). In order to adhere to medications, a patient has to
play an active and voluntary role in the ongoing treatment process. The term
“compliance” is often used interchangeably with “adherence” to describe patient‟s
medication-taking behavior. However, the term “compliance” has come into disfavor
because it suggests that a patient is passively following a doctor‟s orders, rather than
actively collaborating in the treatment process. The term to describe medication-taking
behavior has been discordant in the past literature with a move away from compliance
towards adherence (World health organization. adherence to long-therapies: Evidence for
action. geneva.2003). Understanding a patient‟s medication-taking behavior is an
intriguing and complex phenomenon.
It is estimated that failure to adhere to medication regimens in the United States
results in 125,000 deaths and may cost about $100 billion annually (Hughes, 2004;
Krueger, Berger, & Felkey, 2005; Vermeire, Hearnshaw, Van Royen, & Denekens,
1

2001). Consequences of non-adherence are profound, such as ineffectiveness of treatment
and worsening of disease progression resulting in poor outcomes. Severe disease
complications may lead to patient hospitalization, rehospitalization and emergency
department visits, which in turn increase the economic burden. Very importantly,
medication non-adherence may affect the patient‟s health related quality of life
(Balkrishnan & Jayawant, 2007; Hughes, 2004).
The prevalence of medication non-adherence ranges from 13 to 93%, with an
average rate of 40%, and this range encompasses all ages and ethnic groups (Bond &
Hussar, 1991). The non-adherence rate with medications for acute disease conditions
ranges from 23 to 40%, while this rate ranges from 40 to 75% for long term or chronic
medications (Haynes et al., 1980). This variation is due to inclusion of different
populations, type of study design (e.g. observational study versus clinical trial),
medication class, method of adherence measurement, source of data, and definition of
adherence used (Haynes et al., 1980). Such high rates of non-adherence suggest that
approximately half of the patients with chronic diseases have problems following their
prescribed regimen and that they may not achieve optimal clinical benefit. Chronic
illnesses are more common among older adults and are one of the leading causes of death
and disability in this population (Salzman, 1995).
Adherence is simultaneously influenced by several factors and studies over the past
three decades have identified a number of these factors affecting medication adherence
(Balkrishnan & Jayawant, 2007; Hughes, 2004). The World Health Organization in 2003
suggested that medication adherence can be determined by interplay of five sets of
2

factors, termed as “dimensions” viz. social and economic, health care system, conditionrelated, therapy-related, and patient-related factors (World health organization.
adherence, 2003).
Social and economic factors such as poor literacy level, poor social support,
family instability, limited access to health care, cost of the medications and homelessness
are the most consistently reported factors to impact medication adherence (KrouselWood, Hyre, Muntner, & Morisky, 2005; Krueger et al., 2005). People who have social
support from family, friends, or caregivers to assist with medication regimens have been
found to have better adherence to treatment. Medication beliefs, level of education and
understanding the importance of the treatment and the treatment instructions are also
important factors that affect medication-taking behavior (Gatti, Jacobson, Gazmararian,
Schmotzer, & Kripalani, 2009; Horne & Weinman, 1999). Patients aged 65 or above,
who had more negative beliefs about medications, had 2.1 times greater odds of low
medication adherence compared with patients with less negative beliefs (Gatti et al.,
2009).
The quality of the health care provider-patient relationship is one of the most
important health care system-related factors that affects medication adherence along with
poor access or missed appointment and lack of continuity of care. It has been shown that
a good relationship between the patient and a physician, nurses or pharmacists, which
features encouragement and reinforcement from them, has a positive impact on adherence
(Haskard Zolnierek & Dimatteo, 2009; Krueger et al., 2005; Vik, Maxwell, & Hogan,
2004; Vlasnik, Aliotta, & DeLor, 2005).
3

Two of the most important disease condition-related factors contributing to poor
adherence are undoubtedly the asymptomatic and lifelong nature of the disease (KrouselWood et al., 2005; Krueger et al., 2005). Prevalence of non-adherence is higher in case of
chronic disease conditions than acute disease conditions (Krueger et al., 2005).
Medications have to be taken indefinitely for many chronic illnesses, and adherence to
such treatment regimens often declines significantly over time. Due to lack of immediate
benefit of the therapy for many disease states, some older adults do not adhere to their
treatment (Krousel-Wood et al., 2005; Krueger et al., 2005).
Therapy-related factors affect medication adherence due to the complexity of
medication regimen (no. of meds and no of daily doses), duration of therapy, lack of
immediate benefit of therapy, medications with social stigma attached to it and actual or
perceived unpleasant side effects of the medications. All of these factors lead to
medication non-adherence (World Health Organization, 2003; Krousel-Wood et al.,
2005; Krueger et al., 2005).
Many patient-related factors such as lack of knowledge about the disease and the
reasons why medication is needed, lack of motivation, low self-efficacy, forgetfulness
and substance abuse are associated with poor medication adherence. (Osterberg &
Blaschke, 2005; Vermeire et al., 2001) Some patient-related physical factors such as
vision or hearing impairment, cognitive impairment, limited dexterity, and swallowing
problems also leads to medication non-adherence.
According to the 2000 census, the number of people aged 65 and older in the United
States was estimated to be 35 million and this population accounts for one-third of all
4

health expenditures including prescribed drugs (Raehl, Bond, Woods, Patry, & Sleeper,
2006). Medication non-adherence accounts for 26% of older adult hospital admissions,
nearly 1/4 of nursing home admissions and 20% of preventable adverse drug events
among older adults in community settings (Donovan, 1995; Vermeire et al., 2001). Thus,
adherence is particularly challenging in older adults who often have multiple medical
conditions to manage with a high number of concurrent medications (Hughes, 2004). The
consequences of non-adherence may be more serious, less easily detected, and less easily
resolved in older adults than in a younger age group (Hughes, 2004). In older people,
perceptions of illness and poor comprehension of the role of medicines in the
management of long-term conditions can lead to intentional non-adherence with
medications (Gatti et al., 2009; Lowry, Dudley, Oddone, & Bosworth, 2005).
Hypertension is an especially common chronic illness. According to the National
Center for Health Statistics it is present in 26.7% of the United States population between
ages 20 to 74 (National Center for Health Statistics, 2006). The prevalence of
hypertension among older adults aged 60 and above rose from 58% to approximately
67% over the 10 years (Ostchega, Dillon, Hughes, Carroll, & Yoon, 2007). The seventh
Report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure (JNC 7) has identified that low adherence to
prescribed antihypertensive medications is potentially a major barrier to adequate blood
pressure control and has referred to it as “America‟s other drug problem” (The seventh
report of the joint national committee on prevention, detection, evaluation, and treatment
of high blood pressure).
5

There is a positive, continuous, consistent relationship between blood pressure and
risk of cardiovascular events independent of other risk factors. Cardiovascular diseases
are preventable and primary prevention studies have shown that antihypertensive agents,
including diuretics, β-blockers, calcium channel blockers, angiotensin-converting enzyme
inhibitors, and angiotensin receptor blockers are associated with a 30% to 40% reduction
in the incidence of cardiovascular diseases (Vermeire et al., 2001). However, the large
reductions in risks associated with cardiovascular diseases seen in clinical trials with
these drugs may not translate into better prognoses in the “real-world” setting if patients
have trouble adhering to their prescribed regimens. Non-adherence with antihypertensive
medications leads to suboptimal blood pressure control, high risk of cardiovascular
diseases, more accelerated and severe hypertension, more hospitalizations and premature
death and eventually potentially greater health cost.
Potential reasons for poor medication taking behavior, particularly during
antihypertensive therapy, are cost of medication and related care, unclear instructions,
failure of physician to increase or change therapy to achieve blood pressure goals,
inadequate or no patient education, lack of involvement of patient in treatment plan and
some therapy related factors like side effects of medication and complexity of dosing
regimen (Burnier, 2006; Patel & Taylor, 2002). Effective interventions are needed to
equip health care providers with tools to improve antihypertensive medication adherence
among older adults.
Poor medication adherence has reached crisis proportions in the United States
leading to significant economic cost. Thus it is imperative to understand the factors
6

affecting medication adherence and ultimately to develop effective interventions to
improve adherence (Banning, 2008).
Studies have explored definition, factors associated with nonadherence,
predictors, and consequences of nonadherence. However lack of a “gold standard”
measure to assess medication adherence continues to impose challenges and is the biggest
clinical hurdle that is necessary to target the consequences of medication non-adherence
(Balkrishnan & Jayawant, 2007; Osterberg & Blaschke, 2005).
There are both direct and indirect methods of measuring medication adherence.
The direct method includes biological assay where the presence of a drug or its
metabolite in a biologic fluid provides confirmation that the patient has received a dose of
medication within some period of analysis. The indirect methods of measuring
medication adherence are more frequently reported in the literature and include patient
interviews, diaries, self-report questionnaires, pill counts, pharmacy records, prescription
claims, clinical outcomes, and electronic monitoring.
All the current methods used to measure adherence have some advantages and
disadvantages. When choosing a method for identifying patients who are non-adherent for
an intervention or assessing the outcomes of an intervention to improve adherence for a
particular patient population, it is crucial to evaluate if adherence measured by various
methods agree with each other in the population of interest.

7

Objective and Specific Aims
The main objective of this study was to evaluate the agreement between two selfreport methods, Morisky Medication Adherence Scale (MMAS) and Brief Medication
Questionnaire (BMQ), and prescription refill records to identify an appropriate tool to
measure adherence in independently living older adults with hypertension. Both the
MMAS and BMQ have been previously demonstrated to be reliable measures to assess
medication adherence and they are among the most practical approaches available to
measure adherence. However, a gold standard method to measure adherence in older
adults has not been identified.
The study has the following specific aims:
Specific Aim 1: Measure adherence to antihypertensive medications using MMAS in
older adults.
Specific Aim 2: Measure adherence to antihypertensive medications using BMQ in older
adults.
Specific Aim 3: Measure adherence to antihypertensive medications using prescription
fills records in older adults.
Specific Aim 4: Compare the adherence rate measured by MMAS and prescription fill
records to evaluate agreement between them.
Specific Aim 5: Compare the adherence rate measured by BMQ and prescription fill
records to evaluate agreement between them.
Specific Aim 6: Compare the adherence rate measured by MMAS and BMQ to evaluate
agreement between them.
8

Significance of the study
The U.S Census Bureau reports that by 2030, older adults will account for 20% of
the total U.S. population. The prevalence of hypertension among older adults rose from
58% to 67% in past 10 years. Non-adherence to antihypertensive medications remains a
global problem and imposes financial burden in terms of direct and indirect health care
costs. Promoting patient adherence is a major clinical hurdle that is necessary to decrease
cardiovascular morbidity and mortality (Ostchega et al., 2007; Rizzo & Simons, 1997).
Several studies have previously implemented MMAS and prescription refill records
methods to assess adherence and to understand the underlying reasons for nonadherence(Wetzels, Nelemans, Schouten, van Wijk, & Prins, 2006; Wu, Moser, Chung,
& Lennie, 2008; Zeller, Schroeder, & Peters, 2008). However, lack of a “gold standard”
measure to assess medication adherence continues to impose challenges (Vik et al.,
2004). It is important to address some of the issues in the currently under-researched
realm of medication adherence in older adults.
This will be one of the few studies to include older adults exclusively. The
average age of the residents of the Imperial Plaza is 84 years, thus the results of the study
and the qualitative observations drawn from the participant interviews will contribute to
understanding the patterns of adherence and non-adherence in older adults. Evaluating
agreement between self-report and prescription refill records to assess medication
adherence in older adults will be an important step towards identifying an appropriate
tool to evaluate adherence interventions targeted to older adults. The interview based
self-report method will facilitate the qualitative observations on older adults‟ medication9

taking behavior in detail. The self-report questionnaires used in this study have been
developed and validated for use in hypertensive populations. Adherence rate for all the
antihypertensive medications will be assessed in older adults. The comparison of
adherence rates obtained through these three methods will help establish the reliability
and feasibility of these methods in independent living older adults congregate living
setting. A multi-method approach that combines feasible self-reporting of medicationtaking behavior and reasonable objective measures is the current state-of-the-art in
measurement of adherence behavior (Haynes, Ackloo, Sahota, McDonald, & Yao, 2008;
Kripalani, Yao, & Haynes, 2007).
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CHAPTER 2 LITERATURE REVIEW

This chapter provides a detailed description of the methods available to
identify and quantify medication adherence. Some observational studies that compared
different methods of medication adherence are discussed. As mentioned earlier, the term
“compliance” is often used interchangeably with “adherence” in the literature. This study
particularly focuses on medication adherence, however as the majority of the studies
discussed here use the term compliance; these studies are also included in the literature
review.
To understand the problem of treatment adherence and assess the effectiveness of
interventions to improve adherence, it needs to be accurately measured (McDonald, Garg,
& Haynes, 2002). There are both direct and indirect methods to measure medication
adherence.
The direct method includes biological assay where the presence of a drug or its
metabolite in a biologic fluid provides confirmation that the patient has received a dose of
medication within some period of analysis. Though this is an accurate measure of the
concentration of drug in body fluids, it is intrusive, expensive, and impractical in a nonresearch setting. In addition, this method does not provide information about the type of
non-adherence (intentional or unintentional) and does not detect “white-coat adherence”
11

where the patient may be non-adherent until shortly before a clinic appointment and
return to non-adherent behavior after the clinical visit (Farmer, 1999; Lowry et al., 2005;
Vik et al., 2004).
Biologic markers are nontoxic, stable, easily detected compounds that can be
added to medications. It is impossible to quantify adherence and this method has the
same shortcomings as biologic fluid drug levels (Farmer, 1999).
During direct patient observation patients are closely monitored receiving their
medications. Direct patient observation is feasible during clinical trials and some
institutional settings. Deliberate non-adherent can feign the swallowing the medication
and then remove it from their mouth when they are no longer being observed. This
method is not practical during out-patient settings (Farmer, 1999). These methods are
described in the Table 2.1

Table 2.1: Direct Methods to Measure Medication Adherence

Method

Advantages

Drugs level in
biologic fluids

Provides a confirmation
that the patient has
received a dose

Biologic markers

1) Nontoxic
2) Stable
3) Easy detection
Detail information about
1)
adherence pattern

Direct patient
observation

12

Disadvantages
1) Data limited to recent use
2) Patient-specific kinetic
variation
3) White-coat adherence
1) Data limited to recent use
2) Limited to clinical trials only
1) Impractical in outpatient
setting

The indirect methods of measuring medication adherence are more frequently
reported in the literature and include patient interviews, diaries, pill counts, pharmacy
refill records, prescription claims and electronic monitoring and self-report questionnaire
(Farmer, 1999).
Pill count is simply counting the number of dosage units that the patient has not
taken by the scheduled appointment or clinic visit. The returned dosage units are counted
and compared with the number of units received by the patient in the most recent
prescription and the length of time since the medication was dispensed. It is a simple and
inexpensive method to calculate adherence rate (Haynes et al., 1980). However, the
accuracy of pill counts in estimating actual adherence with a medication regimen can
vary widely. Patients may deliberately not return their medications, some know that the
purpose of their pill counts is to determine their adherence, and they may not return all
the pills to hide their errant behavior. Information on nature of the adherence problem (e.
g., the pattern of missed doses) or the reasons for the problem (e.g. side effects) cannot be
obtained through pill counts (Hansen et al., 2009; Haynes RB, Taylor DW, Sacket DL.,
1979; Haynes et al., 1980)
Patient kept diaries is also an inexpensive and simple method. It provides
information on number and days the pills are missed by a patient. Patient may be able to
document the reason for non-adherence. However, the patient may not truthfully report
the drug intake and patient has to remember to document what pills he forgot to take.
Direct patient observation can be done in clinical trials and some institutional settings.

13

However this method is not practical in outpatient settings (Dunbar J., 1980; Farmer,
1999).
Medication Event Monitoring System (MEMS) cap has been widely used in
studies involving electronic monitoring devices. These electronic devices contain a
microprocessor that records the time and date that the patient obtains a dose of
medication by detecting when a prescription vial or pill box is opened; a pill is removed
from a blister pack or pill ring. Electronic monitoring has significant advantages over
biologic markers and self-report methods in providing continuous, reliable data on actual
medication use. It is useful in determining the precision with which the patient adheres to
the prescribed regimen (Banning, 2009). The data provided by these devices can
determine whether the patient consistently misses the afternoon dose of the 3-times-daily
regimen, for example, or the patient misses doses sporadically. However there is a
possibility of patient accidently or purposefully actuating the medication container
without taking the medications.
Pharmacy records and prescription claims are used to estimate non-adherence and
they are often readily available and provide an “economical approach”. This is the
frequently used objective methods for measuring medication non-adherence. Adherence
rate is calculated by assessing refill gaps. Pharmacy refill records allow the researcher to
study premature discontinuation of therapy. Prescription refill records give (DiMatteo,
2004; DiMatteo, 2004; Kripalani et al., 2007; Steiner & Prochazka, 1997; Vik et al.,
2004)

14

Self report methods have been used in 25.5% of the studies that measured nonadherence (DiMatteo, 2004). Though self reporting measures do not provide an accurate
measure of when and how patients take their medications, it still provides a “relative
understanding of the patient on the adherence dimension” and is inexpensive. (Horne &
Weinman, 1999) It is suggest that self reporting measures are good measures when the
objective of the study is to just identify non-adherers (Haynes RB, Taylor DW, Sacket
DL., 1979). The most widely used self reporting measures of non-adherence are Morisky
Medication Adherence scale (MMAS) (Morisky, Ang, Krousel-Wood, & Ward, 2008),
Medication Adherence Scale (MAS) (MacLaughlin et al., 2005), and Reported
Adherence to Medication (RAM) scale. All these scales are based on the classification of
non-adherence as intentional and unintentional. The questions of this scale measure
patient‟s non-adherence rate relating to forgetfulness and carelessness in taking
medications. Brief Medication Questionnaire (BMQ) is another widely used tool in the
practice settings. BMQ screens patients for non-adherence using regimen screen, belief
screen, recall screen and access screen (Svarstad, Chewning, Sleath, & Claesson, 1999).
These methods are described in Table 2.2.

15

Table 2.2: Indirect Methods to Measure Adherence

Method
Patient-kept diary

Advantages
Self-report method
with regimen data

Disadvantages
1) Potential for overestimation
2) Patient must return diary

Adherence
questionnaire

1) Easy to administer
2) May explain patient
behavior

1) Lack of continuous data
2) Accuracy is instrument
dependent

Pill count

1) Easy to use
2) Inexpensive

Patient may forget or alter
unused portion

Prescription refill
records

1) Noninvasive
2) Long-term data
3) Large populations

Medication Event
Monitoring
System
(MEMS)

1) Knowledge of database
required
2) No information on the actual
consumption
Precise data on regimen 1) Expensive
adherence
2) Inconvenient
3) White-coat adherence

Various models have been established in the past literature like health belief
model, theory of reasoned action, self-efficacy theory, and theory of planned behavior to
study medication adherence (Lau et al., 2008). As evidenced from the literature review,
no single theory can explain medication non-adherence adequately (World Health
Organization 2003). The health belief model is based on the understanding that a person
will take a health-related action if person feels that a negative health condition can be
avoided, if a person has a positive expectations that by taking recommended action or
medication he will avoid a negative health condition and if a person believes that he can
successfully take a recommended health action (Pires & Mussi, 2008; Stafford, Jackson,
16

& Berk, 2008). Patient‟s belief about the necessity of the medications versus their
concerns about potential adverse effects plays very important role in self-management of
medications. Foundation model for medication adherence as defined by World Health
Organization has these three components such as information, motivation and behavioral
skills (World health organization. adherence to long-therapies: Evidence for action.
geneva.2003). Figure 2.1 depicts the foundational model for medication adherence as
described by World Health Organization.

Figure 2.1: Foundational Model for Medication Adherence

Information

Behavioral skills

Behavioral
change

Motivation

MMAS measures patient‟s intentional and non-intentional adherence. This scale
can assess treatment-related attitude and behavior problems that the patient may be facing
can be immediately identified and health care providers may provide reinforcement and
advise such that the patient can take positive steps early to address these issues (Morisky,
Green, & Levine, 1986; Morisky et al., 2008). BMQ has been previously used to examine
17

the relationship between beliefs about medications, health literacy and self-reported
medication adherence. BMQ measures patient‟s beliefs and access to the medications. As
these components help patient adhere to the treatment, this scale is helpful in screening
patients who are non-adherent to their treatment (Svarstad et al., 1999). Thus these two
scales fit well into the concepts derived from health belief model and foundational model
for medication adherence.
When choosing a method for identifying patients who are nonadherent for an
intervention or assessing the outcomes of an intervention to improve adherence for a
particular patient population, it is crucial to evaluate if adherence measured by various
methods agree with each other in the population of interest. For the purpose of this study
adherence to antihypertensive medications was measured using self-report method and
prescription refill records. As mentioned earlier MMAS and BMQ are one of the most
useful and practical self-report measures, hence these two measures were used to measure
adherence in older adults.
The objective of this literature review was to review the studies that have
compared different methods to measure medication adherence in hypertensive patients.

18

Adherence studies comparing different methods to measure adherence

Search Methods
Computerized database searches of English-language articles were conducted in
MEDLINE, and Cochrane Library. Search terms used included hypertension, medication
adherence, medication compliance, patient compliance, patient adherence, and selfreport and prescription data, prescription refill records. The retrieved citations‟ abstracts
were reviewed for relevance. Additional references were obtained from cross-referencing
the bibliographies of selected articles.
Cook et. al. evaluated the concordance among three self-reported measures such
as BMQ, Medication Adherence Survey (MAS) and the Medical Outcomes Study
(MOS) instruments and pharmacy refill. From five primary care physicians‟ office 139
patients aged between 20 and 91, with one or more of following chronic conditions were
enrolled in the study: diabetes mellitus, hormone replacement therapy,
hypercholesterolemia, hypertension and hypothyroidism were included in the study.
Moderate correlations of 0.234, 0.261, and 0.213 were found between refill records and
the MAS, MOS, and BMQ belief screen respectively. Overall high rate of adherence rate
was observed in this population. The study findings underscored the difficulty in both
assessing patient‟s medication-taking behavior and assessing and comparing the results of
adherence research (Cook, Wade, Martin, & Perri, 2005).
Nina van de Steeg et. al. performed a validation study of two established
questionnaires for the measurement of medical adherence of patients treated with
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antihypertensive drugs: MMAS and Medication Adherence Report Scale (MARS-5). It
was concluded from this study MMAS the MARS-5 cannot be recommended to be used
to measure adherence to antihypertensive drugs in the primary care setting at this point.
This study underlined the necessity to validate questionnaires in a specific setting before
using them within a trial different from the original setting of validation (van de Steeg,
Sielk, Pentzek, Bakx, & Altiner, 2009).
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Adherence studies comparing self-report with prescription refill records
Some cross-sectional studies that were done to compare Morisky 4-item scale and
a new 8-item scale (MMAS) and prescription refill records are illustrated in the Table
2.3.
Table 2.3: Adherence Studies Comparing Self-report with Prescription Refill
Records
To assess the level of agreement between a selfGuenette et. Aim
reported measure of adherence and pharmacy data.
al. (2005)
Setting and
study population

 17 pharmacists recruited 189 individuals aged
65 or above
 In-home interview
 All the prescribed drugs for last 4 months

Adherence
measure

 Morisky 4-item was administered
 Continuous Single-Interval Medication
Availability (CMA)
 80% cut-off value
 Adherence by individual and adherence by
drug
 Agreement: kappa statistics

Results

 Adherence rate by self-report: 48%
 Adherence rate by pharmacy records: 50%
 Level of agreement: slight
(kappa=0.16[CI:0.02-0.30])

Conclusion

There is a poor agreement between self-reported
measure of adherence and adherence with
pharmacy records
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Table 2.3: Adherence Studies Comparing Self-report with prescription Refill
Records

Wang
et.al.
(2004)

Aim

To compare self-report (Telephone Survey) and filled
prescriptions to assess how well patients report
noncompliance with anti-hypertensive medications

Setting and
Study
population

 200 antihypertensive patients aged 55 or above from a
large HMO or VAMC

Adherence
measure

 Telephone survey: 1) if you ever missed taking a dose

 Monotherapy

 The frequency with which you missed taking a

dose
 Pharmacy refill records: No. and % of days

covered by antihypertensive medications
 Spearman correlation and kappa statistics
Results

 Poor agreement between the two methods (0.15)
 Very poor agreement between categorical

measures (kappa = 0.12)
Conclusion

 There is a poor agreement between self-reported
measure of adherence and adherence with pharmacy
records
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Table 2.3: Adherence Studies Comparing Self-report with prescription Refill
Records

Krousel-Wood
and Morisky
DE et. al
(2009)

To evaluate the association and
concordance of the new
8-item Morisky Medication Adherence
Scale (MMAS) with pharmacy fill data
Setting and study
population

Adherence
measures

87 community-dwelling seniors with
hypertension aged 65 or above, taking
atleast one antihypertensive medication
 MMAS was administered [high
adherence (score:8), medium adherence
(score 6 to <8) and low adherence
(score <6)
 Adherence rate was calculated by
MPR, CMA, and CMG
 Pharmacy non-persistence: less than 0.8
for CSA and MPR
 less than 0.2 for CMG Agreement: Log
binomial regression model
(% concordance)

Results

 Overall 58%, 33%, and 9% of
participants had high, medium and low
medication adherence by MMAS
 Concordance between MMAS and
CSA, MPR & CMG was 75%

Conclusion

MMAS is significantly associated with
antihypertensive drug pharmacy refill
adherence and further validation of the
MMAS is required
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The conclusion drawn from this literature review is that currently there is no
“gold standard” measure of adherence. All these studies have been performed in various
different settings and various different measures of adherence have been used. However,
assessing medication-taking behavior still remains a challenge. These various adherence
measures have yielded significant differences in estimates across different disease states,
classes of medications, and patient populations. None of the studies have included very
older adults (above the age of 90). Further research is imperative to explore the
medication-taking behavior in the older adults.
This study will evaluate the agreement between three different measures of adherence in
an older adult hypertensive population.
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CHAPTER 3 METHODOLOGY

This chapter explains in detail the methodology that was used in this study. The
first two sections of the chapter explain the aims of the study and the study design. In the
section of study design, the settings in which the study was conducted, study population,
participant recruitment, and data collection methods are described. The third section
explains the instruments that were used to assess medication adherence in older adults
and the final section depicts the analyses that were performed.

Aims of the study
The main objective of the study was to evaluate the agreement between Morisky
Medication Adherence Scale (MMAS) and Brief Medication Questionnaire (BMQ) selfreport methods and prescription refill records.

Specific Aim 1: Measure adherence to anti-hypertensive medications using MMAS in
older adults.
Specific Aim 2: Measure adherence to anti-hypertensive medications using BMQ in older
adults.
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Specific Aim 3: Measure adherence to antihypertensive medications using prescription
refill records in older adults.

Specific Aim 4: Evaluate the agreement between the adherence rate measured by MMAS
and prescription refill records in older adults.
Specific Aim 5: Evaluate the agreement between the adherence rate measured by BMQ
and prescription refill records in older adults.
Specific Aim 6: Evaluate the agreement between adherence rate measured by MMAS and
BMQ in older adults.
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Study Design
Setting
This was an observational cross-sectional study. The study was conducted in a
large independent-living retirement community, Imperial Plaza, located in Richmond,
Virginia. Imperial Plaza‟s community consists of about 850 independently-living
residents. It is one of the largest retirement communities in the state for older adults. The
average age of the residents is approximately 84 years. For the purpose of the current
study this was a suitable setting to recruit older adults, including those above the age of
90 years. Imperial Plaza also has an on-site pharmacy, Plaza Professional Pharmacy, for
their residents. Prescription fill records of the participants were obtained from this
pharmacy. Furthermore, Plaza Professional Pharmacy serves as an experiential training
site for pharmacy students who regularly work with residents in the community providing
medication-related services and education.
The study protocol and consent form were developed in January 2009. This
protocol and consent document was reviewed and approved by the Virginia
Commonwealth University Institutional Review Board, Office of Human Subjects
Protection in March 2009. This study was submitted as an expedited review. Participants
provided informed consent to participate in the study; including consent to access their
prescription records for their antihypertensive medications at Plaza Professional
Pharmacy. Volunteers were provided with an incentive of $10 in “Plaza Dollars” to be
spent for services at Imperial Plaza to participate in the study. This study was funded by
the principal investigator of the study.
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Study population
This study enrolled independently-living older adults residing at Imperial Plaza
who filled their prescription for antihypertensive therapy at Plaza Professional Pharmacy.

Study inclusion criteria:
Volunteers were eligible for the study if they were:
1. Aged 65 years or older.
2. Able to read and converse in English.
3. Residing at Imperial Plaza for more than 6 months.
4. Diagnosed with hypertension.
5. Prescribed at least one antihypertensive medication filled at Plaza Professional
Pharmacy.
6. In control of their own medication administration. Participants could be using a
pill box to organize their medications.

Study exclusion criteria:
Volunteers were excluded from participating in the study if they were:
1. Receiving medications for the treatment of dementia. Potential volunteers were
asked if they were currently taking any medications for cognitive impairment. If
the volunteers answered “yes” to the above question they were excluded from the
study. If the volunteers answered no, but were found to have medications for
dementia in their prescription refill records, they were excluded.
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2. Residents in assisted-living where medications are administered by facility staff.
3. Using mail delivery to receive any of their antihypertensive medications.
4. Unable to provide informed consent.

Participant recruitment
Several approaches were used to recruit volunteers to participate in this study. An
advertising flyer and a brochure describing the study were prepared and approved by the
VCU IRB. The study brochure included an overview of the questions they would be
asked, study eligibility criteria, the purpose of the study and the incentive information.
Participants were asked to participate if they were taking medications for „high blood
pressure‟. Study flyers were posted on the doors to the pharmacy and were distributed to
all residents in the monthly pharmacy newsletter. An announcement about the study was
also included in several issues of the weekly director‟s newsletter in Imperial Plaza
community. In addition, participants in Plaza Professional Pharmacy‟s weekly blood
pressure monitoring program were invited to participate in the study as they waited in
line to have their blood pressure measured. The blood pressure monitoring program is a
free service available to all the residents at Imperial Plaza. Study advertisement flyers and
study brochures were distributed among people who visited weekly blood pressure
sessions. Recruitment brochures were also distributed by the pharmacists at Plaza
Professional Pharmacy along with prescription refills for antihypertensive medications.
Interested residents were provided with a copy of the IRB approved consent form and
given the opportunity to ask questions about study participation. Residents were given
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time to review the consent document with their family and/or health care provider before
deciding to participate.

Data collection
Consent was obtained from the participants prior to their interview. The interview
of each participant took place either in their apartment or the Pharmacy clinic located at
Imperial Plaza, according to their convenience. The data was collected over a period of 3
months. Participants were recruited from April 2009 to July 2009. They were asked to
gather all their blood-pressure lowering medications at the time of the interview.
Interviews were taken with a fixed script for both self-report questionnaires. The overall
time burden to complete data collection for each patient was 30-45 minutes.
The main objective of this study was to assess the agreement between self-report
measure of adherence and adherence based on prescription records measure in older
adults. This study was not powered for statistical tests of significance. The recruitment
goal was to enroll a minimum of 50 patients from the independent-living community.
Thirty-five residents volunteered to participate during the study time period. Three
volunteers were excluded from the study. These volunteers did not have complete
information (6 month refill history) on at least one of their anti-hypertensive medications
in the prescription records. Thus 32 participants were interviewed and records of their
prescription refills were obtained from the on-site pharmacy. Participants‟ prescription
records for antihypertensive drugs were obtained for a period of 6 months starting from
October 2008 to March 2009. The electronic records from the pharmacy included the
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brand or generic name of the prescribed drug(s), the dose, the quantity, the dates the
drug(s) were dispensed, and personal dosage instructions regarding the doses per day and
the pills per dose.
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Adherence Measures
Medication adherence was assessed using 3 previously validated methods:
Morisky Medication Adherence Scale (MMAS) and Brief Medication Questionnaire
(BMQ) and Prescription refill records. All these measures relate to commonly prescribed
medications for hypertension such as diuretics, β-adrenergic receptor antagonists, αreceptor antagonists, angiotensin II receptor antagonists, angiotensin-converting enzyme
inhibitors and calcium channel blockers. For patients prescribed just one of these agents,
the adherence measure reflects just that drug. For patients prescribed 2 or more of these
medications the adherence measure reflects the average adherence among these drugs.

Self –report methods

DiMatteo indicated that self reporting has been used in 25.5% of the studies that
measured non-adherence (DiMatteo, 2004). Self-report is easy to use and is inexpensive,
hence its one of the preferred methods in research as well as clinical practice.
(MacLaughlin et al., 2005) In this study self-reported adherence was measured using the
8-item MMAS and BMQ (Morisky et al., 2008; Svarstad et al., 1999).
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1) Morisky Medication Adherence Scale (MMAS)
Morisky et. al. developed a 4-item medication adherence scale in 1986 (Morisky
et al., 1986). It has been widely used in the literature to measure adherence to
medications for several chronic conditions (Morisky et al., 1986; Raehl et al., 2006;
Rickles & Svarstad, 2007; Spiers & Kutzik, 1995; Stewart, 1987; van de Steeg et al.,
2009). From the previously validated 4-item scale, a new 8-item MMAS was developed
(Morisky et al., 2008). This new scale supplemented additional items to address the
circumstances surrounding non-adherence behavior. Psychometric properties of this 8item scale were determined in a randomized experimental pretest and protest study
design. This was done over a 12-month period in 1367 patients who were diagnosed with
hypertension and were attending an outpatient clinic of a large teaching hospital. A
significant relationship between the adherence scale and blood pressure control was
found (chi-square, 6.6; p<0.05).
Sensitivity and specificity of the 8- item scale were 93% and 53% respectively.
Due to this scale‟s high sensitivity, it could be used to identify patients with low
medication adherence and patients with uncontrolled blood pressure. The specificity
indicates moderate performance of the scale in identifying patients who do not have
problems with medication adherence and have their blood pressure under control relative
to all those with controlled blood pressure (Krousel-Wood et al., 2009; Morisky et al.,
2008). Significant correlation was found between the new 8-item scale and the previous
4-item scale (Morisky et al., 2008). The new scale has been determined to have higher
reliability compared with the 4-item Morisky scale (α = 0.83 vs. α = 0.61).
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The questions in this scale are phrased to avoid the “yes-saying” bias. Since there
is a tendency for patients to give their physicians or other health care providers‟ positive
answers, the wording of the questions in this scale motivates patients to report any
difficulties that they may be facing in following their medication regimen. This is a
simple and economical tool to use and can provide real-time feedback regarding
adherence behavior and potential reasons for poor adherence including social, situational,
and behavioral factors affecting adherence. MMAS has been trichomotized into 3 levels
of adherence, in order to facilitate its use in clinical practice: high adherence (Score 8),
medium adherence (score 6 to <8) and low adherence (score <6). The 8 questions asked
during the interview are given in the Table 3.1.
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Table 3.1: Item on Morisky 8-item scale (Morisky et al., 2008)

No = 0
1. Do you sometimes forget to take your [health concern] pills
2. People sometimes miss taking their medications for reasons
other than forgetting. Thinking over the past two weeks, were
there any days when you did not take your [health concern]
medicine?
3. Have you ever cut back or stopped taking your medication
without telling your doctor, because you felt worse when you took
it?
4. When you travel or leave home, do you sometimes forget to
bring along your [health concern] medication?
5. Did you take your [health concern] medicine yesterday?
6. When you feel like your [health concern] is under control, do
you sometimes stop taking your medicine?
7. Taking medication everyday is a real inconvenience for some
people. Do you ever feel hassled about sticking to your blood
pressure treatment plan?
8. How often do you have difficulty remembering to take all your medications?
Never = 0; Almost never = 1; Sometimes = 2; Quite often = 3; Always = 4
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Yes = 1

Before the interview began, participants were explained the purpose of MMAS
questions. For this reason they were told that patients on blood pressure lowering
medications have identified several issues regarding their medication-taking behavior and
their experiences were of interests for the current study. They were also informed that
there were no right or wrong answers and were asked to answer each question based on
their personal experience with medications (Morisky et al., 2008).
Positive answers obtained for items 1-4, 6, 7, and 8 were coded as yes = 1 and for
negative answers no = 0. Item 8 was divided by 4 to calculate a summated score. This
procedure standardizes the 5-point Likert scale. The total score of the scale ranges from 0
to 8. Participants with the total score of 6-8 were deemed adherent and participants with
the total score below 6 were deemed non-adherent for the purpose of this study.

2) Brief Medication Questionnaire (BMQ) (Svarstad et al., 1999)
Svarstad et. al. developed BMQ which involves a patient interview examining
patient medication use using three subscales or screens: Regimen, Belief, and Recall. The
fourth screen is called as access barrier which evaluates the potential reasons for
medication non-adherence (Svarstad et al., 1999). The sensitivity and reliability of BMQ
was evaluated using Medication Event Monitoring System (MEMS®) in patients who
were prescribed enalopril and captopril (angiotensin-converting enzyme [ACE]
inhibitors). MEMS records each time the cap is opened on the medication vial. Fortyeight participants were randomly assigned to two groups: one group received their
enalopril and captopril in a MEMS container (n = 22) and the other group received a
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standard vial (n = 22). MEMS were considered as a “gold-standard” of adherence
measurement. BMQ was found to have 90% sensitivity and 80% specificity. The
accuracy of BMQ was found to be 85%. This was the first tool which demonstrated that
sensitivity levels vary by type of non-adherence and type of screening tool. Also, this tool
was validated in a test population with multiple drugs and refill prescriptions, which are
the factors known to reduce the sensitivity of self-report adherence measures (Stewart,
1987). Internal consistency as measured by Cronbach‟s alpha, during instrument
developed ranged from 0.55 to 0.86 across diverse populations. (22) Since its
development, the BMQ has been used widely in descriptive research on medication
adherence, and has begun to emerge in intervention studies that involve patient education
and other cognitive intervention components (Haynes et al., 2008).
A newer version of BMQ (2003) with some additional new items to assess
financial barriers, and information on discontinued medication was obtained from the
author. (Svarstad et al., 1999) Permission was obtained to implement the current version
of BMQ in the current study.
The first screen includes 5 items that measure adherence behavior for the past
week and is called the “Regimen screen” for potential non-adherence. Participants were
asked to mention: Medication name and strength, number of days they took the pill,
number of times per day and number of pills they took. They were also asked to mention
if they missed taking any pill and if they said yes then they were asked to mention
number of times they missed taking it. To understand how much a participant knows
about his medication he was asked the reason why he was taking that particular pill.
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If a participant reported “don‟t know” in response to all of the above questions he
indicated a presence of non-adherence and was deemed nonadherent.
The “Belief Screen” measures two beliefs that have been linked to non-adherence
in past studies. These particular items address patient concerns or doubts about the
efficacy of a given medication and concerns about unwanted side effects, short-term or
long-term risks, or other bothersome features of a given medication. Participants were
asked how well the medicine works for them. The response were noted as 1 = very; 2 =
somewhat; 3 = not at all and 4 = don‟t know. Participants were deemed “non-adherent” if
they responded “not well” or “don't know” when asked how well the target medication
works for them and if the medication was identified as bothersome. Item scores are
summed to obtain a total belief score, with positive scores indicating one or more belief
barriers (ranging from 0-2) (Svarstad et al., 1999).
The third screen is called the “Recall Screen” and includes two items that
measure potential problems remembering all doses. Participants were deemed “adherent”
if they had a single dose regimen (once daily) and reported that it is “not at all” hard to
remember all the pills. Participants were deemed “non-adherent” if they had a multiple
dose regimen (two or more times per day), or reported that it is “very” or “somewhat”
hard to remember all the pills, and a score of “2” if both indicators are present (Svarstad
et al., 1999).
The last “access screen” assessed any difficulties opening the container, reading
labels, obtaining refills, and other practical issues participants were facing (Svarstad et
al., 1999). If a participant reported any difficulty paying for medication and difficulty in
38

getting refills in time, participants was deemed to have poor access to the medications
which is a potential barrier to medication adherence. (World Health Organization, 2003)
BMQ screens are shown in the Table 3.2.
Table 3.2: Brief Medication Questionnaire (Svarstad et al., 1999)

1. Regimen Screen (Past week)
a. Medication name and strength
b. How many days did you take it?
c. How many times per day did you take it?
d. How many pills did you take each time?
e. How many times did you miss taking a pill?
f. For what reasons were you taking it?
g. How well does this medicine work for you?
1 = very; 2 = somewhat; 3 = not at all; 4 = don‟t know
2. Belief Screen
Do any of your medications bother you in any way?
a. If „yes‟, please name the medication and explain how it bothers you?
3. Recall screen (Past 6 months)
Did you stop taking any Medications in the past 6 month?
If „yes‟, please tell: a. Medication name
b. For what reason were you taking it
c. How well did the medicine work for you?
1 = very; 2 = somewhat; 3 = not at all and 4 = don‟t know
d. How much did it bother you?
0 = none; 1 = a little and 2 = a lot
e. For what reason did you stop taking it?
4. Access screen
a. My medication causes side effects
b. It is hard to remember all the doses
c. It is hard to pay for the medication
d. It is hard to open the container
e. It is hard to get my refill on time
f. It is hard to read the print on the container
g. The dosage times are inconvenient
h. My medication causes other problems or concern
If any other problem or concern, please explain:
Response: 0 = None 1 = A little 2 = A lot
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3) Prescription Refill records
Prescription refills record is a frequently used method to measure medication
adherence objectively (Kripalani et al., 2007; Vik et al., 2004). With the advent of
centralized computerized refill records, the use of pharmacy prescription refill has
increased dramatically. Pharmacy records used to estimate non-adherence are often
readily available and provide an “economical approach” in estimating adherence (Vik et
al., 2004). More than 200 studies have assessed medication adherence using prescription
records (Andrade, Kahler, Frech, & Chan, 2006). Prescription refill records are very
useful in assessing medication adherence in population-based studies that need to assess
drug exposure retrospectively. Refill compliance measures are also appropriate for
pharmacy-based interventions to improve medication acquisition in clinical settings
(Steiner & Prochazka, 1997).
For the purpose of the current study, adherence rate to antihypertensive
medications in older adults was calculated by Medication Possession Ratio (MPR) using
participants‟ prescription refill records for the past 6 months. Possession of medication is
the required initial step for patients to actually consume the drugs and MPR helps identify
long-gaps in treatment with antihypertensive medication that may lead to adverse
outcomes. Calculating MPR is a well-accepted methodology to measure medication use
in research with pharmacy refill records (Hess, Raebel, Conner, & Malone, 2006). MPR
was defined as supply of medication in days divided by the total number of days between
the first and the last refill date. The value obtained was multiplied by 100 to convert to a
percentage. The numerator was the sum of all days supplied regardless of whether
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prescriptions involved overlapping days. The number of days was counted beginning
from the fill date of the patient‟s first fill pharmacy claim.
Days‟ supply of the last observed pharmacy claim was not included in the
summation of the supply of medication as no antihypertensive pharmacy refill activity
was observed after that refill date for the purpose of our study. Adherence was capped at
100% i.e. MPR values greater than 1 were reduced to 1. Calculations of MPR are
demonstrated in the Table 3.3.

Table 3.3: MPR Calculation to Measure Adherence Rate Using Prescription Refill
Records

30

30

30

30

30

30

Days‟ supply obtained
Date fill occurred

10/3/08

11/4/08
32

12/5/08
31

1/6/09
32

Interval (in days)
MPR = Days‟ supply

= 150/158 = 0.9493 = 94.93%

Interval of days
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2/6/09
31

32

3/10/09

Drug-specific MPR‟s were calculated. For patients who were taking more than
one antihypertensive medication, MPR were calculated for each medication and then
averaged across all the medications to assign a single MPR to each participant. Patients
were categorized as adherent if overall MPR value was 80% or above. Based on previous
studies, 80% cut-off value was used to define adequate medication adherence using
pharmacy refill data. (Sikka, Xia, & Aubert, 2005)
This cut-off was specified a priori and based on a study Psay et. al that indicated
that patients who took less than 80% of their hypertensive medication were at a 4-fold
risk for acute cardiac events than patients who took 80% or more of their medications.
Participants with a MMAS score of 6 or above were deemed adherent, thus the adherence
cut-off correlates well with the prescription refill records cut-off value.
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Data Management and analyses
The main objective of this study was to evaluate the agreement between the selfreport method of medication adherence and prescription fill records in the population
taking blood pressure lowering medications. All study records were stored in a locked file
cabinet in the investigator‟s office. All patient data was de-identified when entered into
the study database in HIPAA compliant manner. The study database was password
protected. Study data was entered into an electronic spreadsheet. All analyses were done
using JMP® 8.
Descriptive statistics including the mean and standard deviation or median and
25th and 75th percentiles for continuous variable or proportion with 95% confidence
intervals for categorical variables were calculated for all demographic and clinical
characteristics measured. Demographic characteristics included age, gender, ethnicity,
socioeconomic status, and co-morbid conditions. To evaluate participants‟ socioeconomic
status they were asked if they had any difficulty paying for their medications in past 6
months. The response was categorized as yes or no. All the participants responded to this
question saying no, they did not have any difficulty paying for their medications in past 6
months. Hence, the demographic variable socioeconomic status was not included in the
analysis. Due to small sample size there was insufficient variability to calculate comorbid conditions using ICD-9 codes thus, this demographic variable was not included in
the analysis.
Clinical characteristics such as class of antihypertensive medications, number of
antihypertensive drugs, and combination drug pill were included in the data analysis.
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Overall adherence rates by MMAS, BMQ, and prescription refill records were
analyzed using distribution statistics. Using the cut-off values and based on participants
responses, they were dichotomized into two groups as adherent and non-adherent.
Participants with the score of 6 to 8 were considered adherent and participants with the
score below 6 were considered non-adherent. For BMQ participants were screened for
non-adherence individually for all the four screens. For MPR the cut-off value of 80%
was used to deem participants adherent and non-adherent.
Kappa (k) statistics was used to define the agreement between MMAS and
prescription refill records, between BMQ and prescription refill records, and between
MMAS and BMQ.
The strength of the agreement was assessed with a commonly used classification
scale for kappa coefficients. Kappa values range from -1 and 1.
-1 to 0.00 = poor, 0.00 to 0.02 = slight, 0.21 – 0.40 = fair, 0.41 – 0.60 = moderate, 0.61 –
0.80 = substantial and 0.81 to 100 = almost perfect (Landis & Koch, 1977).
During the interview individual participants observations on how he/she manages
medication, medication habits, concerns about the medications and any other useful
information were recorded.
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CHAPTER 3 RESULTS

Demographics characteristics
Overall 35 residents volunteered to participate in the study. Of these, 32 met the
inclusion/exclusion criteria. The average age of the participants was 88 (SD = 5.5) years.
The oldest participant was 97 years old and the youngest participant was 76 years old.
There were 14 (43.8%) participants aged 90 and above and 18 (56.3%) participants who
were aged 89 or below. Out of total of 32 participants, there were 21 (65.6%) women and
11 (34.4%) men in the study. There were 30 (93.7%) Caucasian participants whereas
there were 2 (6.25%) African-American participants in the study. Thus very little ethnic
diversity was present in the population. Participants‟ socioeconomic status was assessed
by asking them, whether they had any difficulty paying for their medications in the past 6
months. It was found that all the participants had no difficulty in paying for their
medications. Due to Medicare Part D they were more likely to be able to afford their
medications than uninsured populations. Patients‟ demographic characteristics are shown
in Table 4.
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Table 4.1: Participant’s Demographic Characteristics

Variables
Age in years
≤ 89
≥ 90
Gender
Men
Women
Race
Caucasian
African-American
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N (%)
18(56.3%)
14(43.8%)
11(34.4%)
21(65.6%)
30(93.8%)
2(6.3%)

Clinical characteristics
Overall 23 (71.9%) participants were taking diuretics. Diuretics are the first line
therapy for isolated systolic hypertension according to treatment guidelines for blood
pressure management (The seventh report of the joint national committee on prevention,
detection, evaluation, and treatment of high blood pressure (JNC 7).December 2003).
Only 7 (21.9%) participants were taking monotherapy for hypertension. Overall
17 (53.1%) participants were taking 2 antihypertensive medications, 7 (21.9%)
participants were taking 3 antihypertensive medications. Only 1 (3.1%) participant was
taking 4 antihypertensive medications.
Of the 32 participants 7 (21.9%) were taking just 1 pill and 12 (37.5%)
participants were taking two pills and rest 13 (40.6%) participants were taking 3 or more
number of pills per day.
Overall 20 (63%) of the participants were using pill boxes to manage their
medications.
Overall 9 (28.1%) participants were taking a combination product of
antihypertensive medications. The clinical characteristics of the patients are shown in
Table 4.2.

47

Table 4.2: Participant’s Clinical Characteristics

Variable
No. of drugs
1
2
3
4
No. of pills
1
2
Combination pill
Yes
No

N (%)
4(12.5%)
20(62.5%)
7(21.9%)
1(3.1%)
7(21.9%)
12(37.5%)
9(28.1%)
23(71.8%)

The overall adherence rates measured by prescription refill records, MMAS,
BMQ regimen, BMQ belief and BMQ recall screens were 84.4%, 59.4%, 68.8%, 93.4%
and 59.4% respectively.
Out of 14 participants aged 90 or above, 11 participants (78.6%) were found to be
adherent according to MPR and BMQ Regimen barrier. Ten participants (71.4%) were
found to be adherent according MMAS and BMQ recall screen. All the older adults aged
90 and above had 100% adherence rate according to BMQ belief screen.
In contrast; out of 18 participants aged 89 or below, 16 participants (88.9%) were
found adherent according to MPR and BMQ belief screen. Based on MMAS and BMQ
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recall screen 9 (50%) of the participants were adherent to their antihypertensive
medications. According to BMQ regimen screen, 11 participants (61.1%) were adherent.
Participants aged 90 and above were found to be more adherent to their
antihypertensive medications according to MMAS and BMQ belief screen. The
adherence rate in different age groups is shown in the Table 4.3.

Table 4.3: Adherence Rate Across Two Age Groups

Adherence measure

MPR

Adherence rate
Participants
aged ≥ 90 (n=14)
11 (78.6%)

Adherence rate
Participants
aged ≤ 89 (n=18)
16 (88.9%)

MMAS
BMQ regimen screen
BMQ belief screen
BMQ recall screen

10 (71.4%)
11 (78.6%)
14 (100%)
10 (71.4%)

9 (50%)
11 (61.1%)
16 (88.9%)
9 (50%)
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Agreement between adherence measures
Very poor agreement between prescription refill records and self-report measures
was observed. There was a slight agreement between MMAS and BMQ belief screen and
substantial agreement between MMAS and BMQ regimen screen. Good agreement
between MMAS and BMQ recall screen was observed.
Very poor agreement between prescription refill data and MMAS self-report
(kappa = -0.004), prescription refill data and BMQ regimen screen (kappa = -0.095),
prescription refill data and BMQ belief screen (kappa = -0.098) and between prescription
fill data and BMQ recall screen (kappa = -0.004) was found.
Slight agreement between MMAS and BMQ belief screen was found (kappa =
0.18). However, substantial agreement between MMAS and BMQ regimen screen was
observed (kappa = 0.80). There was a good agreement between MMAS and BMQ recall
(kappa = 0.87). Agreement kappa values are shown in the Table 4.4.

Table 4.4: Agreement Statistics
Adherence measure
Prescription refill records & MMAS

Kappa
value
-0.004

Strength of
agreement
Poor

Prescription refill records & BMQ Regimen Screen

-0.095

Poor

Prescription refill records & BMQ Belief Screen

-0.098

Poor

Prescription refill records & BMQ Recall screen

-0.004

Poor

MMAS and BMQ Regimen screen

0.18

Slight

MMAS and BMQ Belief screen

0.80

Substantial

MMAS and BMQ Recall screen

0.87

Good

50

Qualitative observations

1) Residents of Imperial Plaza were somewhat hesitant to participate in the study.
Some residents seem to believe that participation in research studies is harmful.
They like to consult their physician or family before participating in the study.
Some of the residents were not willing to participate because they had hearing
impairment.
2) Most of the participants were very disciplined and organized with their
medications. They stored them at a fixed place or in weekly pill boxes so that they
could remember to take them all the time. Most of the participants were using
weekly/daily pill boxes as an aid for them to be able to remember to take their
medications. However, some residents would say that they had taken their
medications even though pills were found in the pill boxes that should have been
taken.
3) One of the resident had already participated in the study and she was found to be
adherent with both self-report methods and prescription refill data. However, she
had no recollection of participating in the study after a month and she showed
interest in participating again. This observation questions the reliability of selfreport questionnaires.
4) It was observed that participants aged above 90 years were less likely to report
that they have missed taking their medications. They seemed to want to believe
that with increasing age they still have good memory and were proud of this fact.
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This belief was supported by the relatively higher rate of adherence found in them
as compared to those aged below 90 years. Participants did mention that they
sometime do not take their medications in the morning if they want drive or go
out, as their antihypertensive medication makes them feel dizzy.
5) The study population had easy access to medications because only residents who
were filling their prescription for antihypertensive medications at on-site Plaza
Pharmacy were recruited in the study.
6) There was a positive atmosphere and a very encouraging patient-pharmacist
relationship present in the community. It has been shown that the pharmacists in
collaboration with physicians can play an active role in increasing medication
adherence (Haskard Zolnierek & Dimatteo, 2009; McDonald et al., 2002;
Mihalko et al., 2004; Sullivan). Pharmacists at Plaza Professional Pharmacy were
very efficient in developing friendly relationships with their patients and
communicating the benefits of the treatment to them. This information was
gathered during BMQ access barrier, when participants were asked if they had
any difficulty getting their refills on time.
7) Most of the participants were chronic users of antihypertensive medications and
they did understand the benefits of the treatment. None of the participants were
found to be at risk for non-adherence when screened with BMQ belief screen.
Strong health beliefs are required to adhere to the treatment (Lau et al., 2008;
Lowry et al., 2005).
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From all the above observations it is clear that, there is no single reason for
medication non-adherence thus there can be no “one size fits all” approach to improving
adherence (World health organization, 2003).
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CHAPTER 5 DISCUSSION

The main purpose of this study was to assess agreement between adherence as
measured by two different self-report methods and prescription refill records in older
adults taking medications for hypertension. Main finding and strengths of the study will be
discussed in this chapter. This chapter will also address the study‟s limitations and future
directions.

Main finding
Poor agreement was found between self-reported medication adherence and
adherence measured using prescription refill record. When MMAS and the BMQ were
compared with each other, substantial agreement was found. This indicated that both these
methods address patients‟ adherence in a comparable way. Older adults aged above 90
years had greater rate of adherence with self-report questionnaires than participants aged
below 90. This explains that patients with good adherence have better perception about
their medications and stronger beliefs about the benefits of the medications.
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Adherence measures
This is one of the few studies that evaluated agreement between three adherence
methods by interviewing patients with the questionnaires, exclusively in older adults.
Previous studies that have evaluated the agreement between self-report methods and
prescription fill records have also found similar results as the current study (Cook et al.,
2005; Wang et al., 2004).
Non-adherence in a population of older adult patients with congestive heart failure
has been assessed using self-report method and similar results as the current study were
found. The oldest elderly patient (>85 years old) had the highest adherence rate (Monane,
Bohn, Gurwitz, Glynn, & Avorn, 1994). From the analysis of the current study it was
found that older adults aged above 90 had higher rate of self-reported adherence than those
aged below 90.
Recently one study validated MMAS 8-item scale and Medication Adherence
Report Scale (MARS-5) for the measurement of adherence of 128 patients treated with
antihypertensive drugs in primary care in Germany. Prescription refill records were used as
a reference standard to compare these two self-report methods. The two questionnaires
overestimated patients‟ adherence and turned out to be invalid for the setting they were
used. However, reasonable specificity (72.8%) was found for MMAS (van de Steeg et al.,
2009). However, the study did not include older adults specifically.
Thus the current study results are consistent and in agreement with other studies
showing that the adherence as measured by self-report does not agree with the adherence
measured using pharmacy records.
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The discrepancies between the self-report method and prescription fill records
adherence rate may be explained in different ways. First, these methods measure different
concepts of adherence. MMAS recognizes patient‟s intentional and unintentional
nonadherence whereas BMQ addresses the specifics of the therapeutic regimen, patient‟s
beliefs about a particular regimen, and assess patient‟s access to the medications.
Prescription refill records indirectly measure adherence by examining the length of time
and quantity of medication acquired by the patient. Thus this method provides only a rough
average of overall medication-taking behavior. It documents a patient‟s actions rather than
a patient‟s intention.
Another explanation for the poor agreement is that self-reported measures evaluate
adherence rate over different time frames. BMQ itself evaluated patient‟s medicationtaking behavior over a period of a week, two weeks, and 6 months. Prescription fill data
measured patients‟ medication taking behavior for the longest period of time. Participants
6 month‟s prescription refill records were analyzed to calculate their adherence rate. Good
agreement between MMAS and BMQ can be explained by the similar structural formats of
the two measures.
Even though patients‟ self-report is the easiest and most common method to
measure adherence, it involves a risk of social desirability bias which may lead to
overestimation of adherence (Raehl et al., 2006). It was observed in this study that older
adults aged above 90 tend to give positive answers. Perhaps they have a tendency to want
to show that, in spite of their old age, their memory is still good. They may do so with the
intention to want to maintain their independent-living status. With the intention of
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minimizing the social desirability bias in the study, participants were informed that
information collected from their interviews would remain confidential. Most of the
participants were interviewed at their homes to provide them with a more comfortable and
familiar environment. The assumption behind this was that, this surrounding and detail
information on the study will help them to be more honest and open about their
medication-taking behavior and concerns. For example, one study pointed out that in a
general practitioner‟s office patients may not be very willing to reveal their medication
taking habits (van de Steeg et al., 2009). Practitioners may also be biased towards enrolling
only adherent patient in studies (Spiers & Kutzik, 1995; van de Steeg et al., 2009). The
interviewer of this study was not aware of participants‟ medication-taking habits at all,
potentially reducing this type of bias in this study.
In this study, 63% of the participants were using weekly or daily pill boxes which
are either filled by the participant, a family member or the pharmacist at Plaza Professional
Pharmacy. In such a situation, when positive response for self-report questionnaires was
obtained, the interviewer asked the participant to show the weekly pill containers. Some
people did not take their weekly dose of the therapies evidenced by pills remaining in the
pill box on days that should be empty, but reported that they did so. This may indicate that
self-reported adherence is not always an accurate measure for older adults (Vik et al.,
2004).
BMQ examines the patient‟s intentions and knowledge with respect to their
medications. It was observed that some of the patients adhered to their therapy simply
because physician instructed them to do so without understanding the purpose or goals of
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therapy. On the other hand some patients do understand all the benefits of a give therapy,
yet either choose not to adhere to avoid adverse drug reactions or they do not trust their
prescribers (Guenette, Moisan, Preville, & Boyer, 2005). Considering the population of
this study, most of the patients aged above 90 seemed concerned about their health and
were disciplined with their medication-taking behavior. This may result in them having
better health and quality of life than those who do not adhere to their therapy.
Pharmacy refill records also have some limitations. This method provides only a
rough average of overall medication-taking behavior and documents patient‟s action rather
than a patient‟s intention (A. Christensen, Osterberg, & Hansen, 2009; D. B. Christensen et
al., 1997). It may underestimate the adherence rate if there is missing data on the
prescription. For example, the mediations may be supplied by a different pharmacy for a
period of time. However, this limitation did not impinge on the results of this study, as
only the participants who refilled their prescriptions at the on-site Plaza Pharmacy were
enrolled in the study. During hospitalization, medications are provided by the hospital and
would appear as a gap in refill history. The refill history indicates nonadherence in this
case, when the resident was actually adherent (Claesson, Morrison, Wertheimer, & Berger,
1999).
The cut-off value of 80% for adherence as assessed by prescription refill history
was chosen based on past literature. Psay et. al performed a study that indicated that
patients who took less than 80% of their hypertensive medication were at a 4-fold risk for
acute cardiac events than patients who took 80% or more of their medications (Bramley,
Gerbino, Nightengale, & Frech-Tamas, 2006; Psaty, Koepsell, Wagner, LoGerfo, & Inui,
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1990). However, there is a need to clinically evaluate the level of medication adherence
that distinguishes clinically significant adherence versus non-adherence (Karve et al.,
2009). Longitudinal studies that measure medication adherence using a combination of
subjective and objective method are required to determine the unambiguous cut-point
above which there is a positive relationship between level of medication adherence and
significant clinical outcomes for hypertensive patients (Wu et al., 2009; Wu et al., 2009).
The adherence rate should be analyzed as a continuous measure instead of dichotomizing it
using the 80% cut-off value for MPR values (Wu et al., 2008).
Issues related to difficulty accessing medication could not be evaluated in this
study. Residents of one of the largest independent-living communities in Virginia
participated in this study. This population has a relatively high socioeconomic status and
participants indicated no difficulty paying for their medications. This population is eligible
for Medicare Part D, which makes it more likely that they will have prescription drug
coverage. This population had higher rates of adherence due to lesser issues with
accessing their prescription drugs as they do not have transportation issues impairing their
ability to get their medications. Previous studies have shown that African-Americans have
poor medication adherence compared to Caucasian population (Cooper, 2009; Rizzo &
Simons, 1997). The possible explanations for non-adherence were found to be low literacy
levels and poor socioeconomic status among African-Americans (Cooper, 2009). As the
study population was predominantly Caucasian, this may have also contributed to
relatively high adherence rates in the study.
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Wang. et. al. conducted a telephone survey on 200 hypertensive patients treated
with a single anti-hypertensive agent in a large HMO to obtain self-reports of the
frequency of missing antihypertensive therapy (Wang et al., 2004). In a population of older
adults, particularly in those aged above 90 this method of a telephone survey may not be
feasible due to communication difficulties for some older adults due to age-related hearing
impairment. It is more challenging to interview older adults over the phone or through
internet based services in order to understand their medication-taking behavior.
Interviewing older adults with the self-report questionnaires is an ideal way to collect
information on their medication-taking habits and to understand if they have any concerns
with the treatment.
However, it was challenging to enroll older adults, especially older adults aged
above 90 in this study as they were quite hesitant to participate. Some had the notion that
they are put at risk during research studies and it is not necessary for them to participate.
Some of the participants consulted their physicians or family before participating in the
study. It was definitely very difficult to communicate the study purpose to these older
adults. Some of the residents from independent-living facility called the interviewer to
volunteer to participate and when they were contacted back to schedule an appointment
they had no memory of volunteering to participate in the study. This suggests that even
though these residents were living in an independent-living facility they might have been
suffering from mild cognitive impairment.
The study was designed to compare three different adherence measures. Neither the
self-report method nor the pharmacy-based adherence measure was considered to be the
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gold standard for the purpose of this study. Unlike much of the prior literature in this area,
this study focused exclusively on older adults and the average age was 88 years. It is still
not clear that, whether chronic users have better adherence rates than those who newly
being the therapy (Mallion, Baguet, Siche, Tremel, & de Gaudemaris, 1998; Mihalko et al.,
2004). However, all the participants were chronic users of the antihypertensive
medications, as found from their prescription refill history. This may have prevented
confounding from the differences in medication adherence found between those who are
just beginning a new medication regimen and those who have been following the regimen
for a long time.
Overall this study contributes significantly to understanding if the self-report
methods and prescription refill records are in agreement and also in evaluating older
adults‟ medication-taking behavior qualitatively.
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Limitations
The main limitation of this study was the small sample size. Less variability in the
sample size prevented formal analysis of the predictors of adherence such as increasing
age, polyphrmacy, and co-morbid conditions in older adults. It would have been interesting
to see how these predictors affect the adherence rate among older adults aged above 90
since there have been varying results on these predictors in the past literature. This study
was limited to older community-dwelling adults with managed care insurance and may not
be representative of patients from other socioeconomic backgrounds.
Imperial Plaza‟s independent-living retirement community provides its residents
with readily accessible pharmacy system and services. The weekly blood pressure
monitoring program at Plaza pharmacy helps create awareness for benefits of the
hypertension drug therapy among the residents. The results of the study are biased towards
good adherence, because these facilities, education, and knowledge may have helped
participants of the study to have positive attitude towards their antihypertensive treatment.
The study population had very little racial, ethnic, and cultural diversity. According to
Virginia department of aging, Virginia's older population is growing more racially and
ethnically diverse, reflecting the growing racial and cultural diversity of the
Commonwealth and the nation (Virginia department for the aging.)
The methods used to measure adherence rates in the study have some shortcomings
too. The possibility of patients being affected by social desirability bias during interviews
cannot be rejected. Different time frames of the self-report questionnaires and prescription
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refill records may have lead to the disagreement between the measured adherence rates.
MPR 80% cut-off value to identify adherent and non-adherent patients is not based on
empirical data.
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Future Directions
Further research should be directed in refining the results obtained from this study.
There is a need to carry out similar studies in more ethnically and culturally diverse larger
patient populations. A multi-center study would add to the generalizability of the study
results. The issue of understanding different predictors of adherence especially in older
adults aged above 90 could perhaps be addressed in future studies by including a more
diverse patient population. For example, a self report method that may work well for a
middle aged population may not be the most preferred approach in the older population.
Thus from the available self report tools, we may need to determine which one would be
the best to use in the older population.
There is a need to have a well-defined, valid, reliable, cost-effective tool that is
accepted by both health care providers and patients to measure medication adherence.
Widespread use of such a tool, which could provide insight into modifiable factors
regarding adherence in different patient populations would lead to better understanding of
nonadherence and lay the groundwork for interventions aimed at increasing adherence to
therapies (McDonald et al., 2002). Adherence needs to be measured as a continuous
variable, rather than categorizing it as adherent or non-adherent behavior, to ensure that all
variations in treatment behavior are adequately captured (Mihalko et al., 2004).
To advance the research in this area it will be necessary to understand the
medication-taking behavior of older adults with mild cognitive impairment in more depth
as well.
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Conclusions
The study was aimed at evaluating the agreement between self-report method and
prescription refill records to measure antihypertensive medication adherence in older
adults. Poor agreement between both self-report methods and prescription refill records
was found. Substantial agreement was found between MMAS and BMQ, suggesting that
both these self-report methods measure adherence in a comparable manner. Adherence rate
was found to be greater in the study participants who understood the benefits of the
treatment than those who did not understood them, which was observed with BMQ belief
screen. Participants aged above 90 reported relatively higher rates of adherence with selfreport than participants aged below 90. Composite measurement strategies that incorporate
multiple types of measures are needed to assess adherence accurately.
Selection of a useful and reliable adherence measure in pharmacy practice is
required, to screen for older adults who are non-adherent to their antihypertensive
treatment and to evaluate outcomes of interventions to improve adherence. These findings
suggest that further validation of these measures to assess medication adherence in older
adults is required.
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RESEARCH SUBJECT INFORMATION AND CONSENT FORM
TITLE: Measurement of Adherence to Anti-hypertensive Medications in Older Adults
Using Self-report Compared to Prescription Fill records.
VCU IRB NO.: HM12071
SPONSOR:

N/A

This consent form may contain words that you do not understand. Please ask the study
staff to explain any words that you do not clearly understand. You may take home an
unsigned copy of this consent form to think about or discuss with family or friends before
making your decision.
PURPOSE OF THE STUDY
The purpose of this research study is to compare three different methods of determining
whether older adults with high blood pressure are taking their medications as prescribed.
You are being asked to participate in this study because you are over the age of 65, are
taking at least one medication for high blood pressure, and have your prescriptions filled at
Plaza Professional Pharmacy.
DESCRIPTION OF THE STUDY
If you decide to be in this research study, you will be asked to sign this consent form. In
this study you will be complete two questionnaires about your use of medication for high
blood pressure and may be asked additional questions about your medications for high
blood pressure. With your consent, your prescription records during the last 6 months at
Plaza Professional Pharmacy will also be reviewed. Participating in the study will take
approximately one hour. No personal information about you will be revealed to staff or
residents of Imperial Plaza during or after the study. Participants in the study will receive
$10 in “Plaza Dollars” that can be spent for services at Imperial Plaza. Any new
information that becomes available during the course of this research study which may
relate to your willingness to continue participation will be provided to you.
BENEFITS TO YOU AND OTHERS
There is no direct benefit to you if you join this study. Participating in this study may
benefit other individuals in the future to better manage their medications for high blood
pressure and be adherent to them. This is not a treatment study. There is no guarantee that
you will receive any medical benefits from being in this study.
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COSTS
There are no costs for participating in this study other than the time you will spend in the
sessions.
PAYMENT FOR PARTICIPATION
There is no compensation, but you will be offered an incentive of $10 in “Plaza Dollars”
that can be spent for services at Imperial Plaza.
CONFIDENTIALITY
Information about you is being collected for research purposes only. All personal
identifying information will be kept in password protected files, and these files will be
deleted or destroyed upon completion of the study. Access to all data will be limited to
study personnel.
Results of this study may be presented at meetings and published in scientific journals, but
your name will not be used in these presentations or papers.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
You do not have to participate in this study. If you choose to participate, you may stop at
any time without any penalty.
Your participation in this study may be stopped at any time by the study staff if you have
not followed the instructions or the study staff thinks it is necessary for your health or
safety.
QUESTIONS
In the future, you may have questions about your participation in this study. If you have
any questions, complaints, or concerns about the research, contact:
Patricia W. Slattum, Pharm.D., Ph.D.
Vice-Chair for Graduate Studies
Associate Professor and Geriatric Specialist
Department of Pharmacy
Virginia Commonwealth University
410 N. 12th Street, Rm 454, Box 980533
Richmond, VA 23298-0533
(804)828-6355 FAX 828-8359
pwslattu@vcu.edu
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Priyanka Kakad, B. Pharm, MS student.
VCU School of Pharmacy
804-402-9352
If you have any questions about your rights as a participant in this study, you may contact:
Office for Research
Virginia Commonwealth University
800 East Leigh Street, Suite 113
P.O. Box 980568
Richmond, VA 23298
Telephone: 804-827-2157
You may also contact this number for general questions, concerns, or complaints about the
research. Please call this number if you cannot reach the research team or wish to talk to
someone else. Additional information about participation in research studies can be found
at http://www.research.vcu.edu/irb/volunteers.htm.
CONSENT
I have been provided with an opportunity to read this consent form carefully. All of the
questions that I wish to raise concerning this study have been answered.
By signing this consent form, I have not waived any of the legal rights or benefits, to
which I otherwise would be entitled. My signature indicates that I freely consent to
participate in this research study. I will receive a copy of the consent form once I have
agreed to participate.

Participant name printed

Participant signature
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ATTENTION!!
DO YOU HAVE HIGH BLOOD PRESSURE?
Virginia Commonwealth University School of Pharmacy is conducting a study of older
adults taking medications for high blood pressure who manage their own medications
The purpose of the study is to compare several different ways of measuring how
patients take their medications
Participants will spend approximately one hour being interviewed by the researcher and
completing two brief questionnaires
If you are aged 65 and above and if you fill your prescription for your blood pressure
lowering medications at Plaza Professional Pharmacy please contact
Dr. Patricia Slattum, PharmD, PhD,
School of Pharmacy Virginia Commonwealth University
804-828-6355
pwslattu@vcu.edu
Participants will receive $10 in “Plaza Dollars”!!
2-16-2009
APPENDIX 1: Commonly used antihypertensive medications
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August 2007 - Present

Virginia Commonwealth University, School of Pharmacy,
Richmond, VA
Masters of Science, Geriatric Pharmacotherapy candidate,
to be awarded in August 2009

October 2003 - May 2007

University Institute of Chemical Technology,
Mumbai, India
Bachelor‟s of Pharmaceutical Sciences (B. Pharm. Sci.)

June 2001- June 2003

Saraswathi Education Society, Mumbai, India
Higher Secondary Education (HSC)

Industrial Work Experience
June 2006 – July 2006

June 2005 – July 2005

Pfizer Ltd, Mumbai, India
Student intern

Navketan Pharma Pvt. Ltd, Aurangabad, India
Industrial trainee
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